Clinical Trial Update: Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effect of ezetimibe on flow-mediated brachial artery reactivity in healthy subjects and has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: University of California, San Diego | Conditions: Endothelial Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2020-02-12